Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Microbiota and Immunotherapy in Breast Cancer - A Review of Recent Developments
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-28
DOI
10.3389/fonc.2021.815772
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure
- (2021) Tsvetelina Velikova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Microbiota and Breast Cancer—Is There Any Relevant Link?—A Literature Review and New Horizons Toward Personalised Medicine
- (2021) Diogo Alpuim Costa et al. Frontiers in Microbiology
- Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
- (2021) Shafiul Haque et al. SEMINARS IN CANCER BIOLOGY
- The Role of Gut Microbiota in Tumor Immunotherapy
- (2021) Miao Wu et al. Journal of Immunology Research
- Tumor mutational burden and PTEN alterations as molecular correlates of response to PD-1/L1 blockade in metastatic triple-negative breast cancer
- (2020) Romualdo Barroso-Sousa et al. CLINICAL CANCER RESEARCH
- Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy
- (2020) Lin Shui et al. Frontiers in Immunology
- A phase Ib/II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (mTNBC) (ENHANCE 1).
- (2020) Sara M. Tolaney et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulation of gut-preactivated naïve CD8+T cells enhances antitumor immunity in B cell-defective mice
- (2020) Maryam Akrami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
- (2020) Aurora Laborda-Illanes et al. Cancers
- Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
- (2020) Javier Cortes et al. LANCET
- A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
- (2019) Takeshi Tanoue et al. NATURE
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- Potential Role of Gut Microbiota in Induction and Regulation of Innate Immune Memory
- (2019) Shikha Negi et al. Frontiers in Immunology
- The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
- (2018) Vancheswaran Gopalakrishnan et al. CANCER CELL
- Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice
- (2018) Concetta Panebianco et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics
- (2018) Ellen M. Wilkinson et al. MATURITAS
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Distinct Microbial Signatures Associated With Different Breast Cancer Types
- (2018) Sagarika Banerjee et al. Frontiers in Microbiology
- Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
- (2018) Concetta Panebianco et al. Microbiome
- The Human Gut Microbiome – A Potential Controller of Wellness and Disease
- (2018) Zhi Y. Kho et al. Frontiers in Microbiology
- Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
- (2018) Sylvia Adams et al. JAMA Oncology
- Checkpoint inhibitors in hematological malignancies
- (2017) Chi Young Ok et al. Journal of Hematology & Oncology
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer
- (2016) Y. Asano et al. BRITISH JOURNAL OF SURGERY
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
- (2016) Ashley Cimino-Mathews et al. HUMAN PATHOLOGY
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis
- (2016) Xue Li et al. Targeted Oncology
- Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
- (2016) Krista Dubin et al. Nature Communications
- Revised Estimates for the Number of Human and Bacteria Cells in the Body
- (2016) Ron Sender et al. PLOS BIOLOGY
- Investigation of the Association Between the Fecal Microbiota and Breast Cancer in Postmenopausal Women: a Population-Based Case-Control Pilot Study
- (2015) James J. Goedert et al. JNCI-Journal of the National Cancer Institute
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Cancer and the microbiota
- (2015) W. S. Garrett SCIENCE
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Investigation of the Association Between the Fecal Microbiota and Breast Cancer in Postmenopausal Women: a Population-Based Case-Control Pilot Study
- (2015) James J. Goedert et al. JNCI-Journal of the National Cancer Institute
- Pharmacomicrobiomics: The Impact of Human Microbiome Variations on Systems Pharmacology and Personalized Therapeutics
- (2014) Marwa ElRakaiby et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Immunity at the Barriers
- (2013) Yasmine Belkaid et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Role of the intestinal microbiome in health and disease: from correlation to causation
- (2012) Willem M de Vos et al. NUTRITION REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Microbiome and Malignancy
- (2011) Claudia S. Plottel et al. Cell Host & Microbe
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
- (2008) S. Ladoire et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now